Re: ZEN-3694 mCRPC Trial Status
in response to
by
posted on
Oct 26, 2017 01:28PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Toniv,
Look back at Masila's unofficial transcript from the Jan 2016 Zenith AGM....in particular the Q&A session. He addressed many of your recent concerns there.....however, it will be great to revisit these topics at the 2017 AGM on Dec 12 to hear what DM's current thinking is on this.
BearDownAZ